Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform

Clinical Lung Cancer

Volumn 16, Issue 3, 2015, Pages 165-172

  Gandara, David R ^a   Mack, Philip C ^a   Bult, Carol ^b,d   Li, Tianhong ^a   Lara, Primo N ^a   Riess, Jonathan W ^a   Astrow, Stephanie H ^c   Gandour Edwards, Regina ^a   Cooke, David T ^a   Yoneda, Ken Y ^a   Moore, Elizabeth H ^a   Pan, Chong Xian ^a   Burich, Rebekah A ^a   David, Elizabeth A ^a   Keck, James G ^b,d   Airhart, Susan ^b,d   Goodwin, Neal ^b,d   De Vere White, Ralph W ^a   Liu, Edison T ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JACKSON LABORATORY   (United States)

^c Response Genetics Inc   (United States)

^d JACKSON LABORATORY   (United States)

Author keywords

Clinical trials; Lung cancer; Mouse model; Patient derived xenograft

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; DNA;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER PATIENT; CANCER RESISTANCE; CANCER STAGING; CHROMOSOME; CLINICAL RESEARCH; CLONAL EVOLUTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; DRUG SENSITIVITY; GENE DOSAGE; GENE EXPRESSION; GENETIC HETEROGENEITY; GENOMICS; HUMAN; INTERVENTION STUDY; MOLECULAR RECOGNITION; MOLECULARLY TARGETED THERAPY; MOUSE; NEXT GENERATION SEQUENCING; NOD SCID GAMMA MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; ONCOGENE; PERSONALIZED MEDICINE; PHARMACODYNAMICS; REVIEW; TUMOR BIOPSY; TUMOR XENOGRAFT; XENOTRANSPLANTATION; ANIMAL; CARCINOMA, NON-SMALL-CELL LUNG; GENETICS; LUNG NEOPLASMS; NONOBESE DIABETIC MOUSE; PROCEDURES; SCID MOUSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; GENOMICS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED NOD; MICE, SCID; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84928697142     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2015.03.001     Document Type: Note

References (26)

1. I. Collins, and P. Workman New approaches to molecular cancer therapeutics Nat Chem Biol 2 2006 689 700
2. P. Workman Genomics and the second golden era of cancer drug development Mol Biosyst 1 2005 17 26
3. Y. Daigo, A. Takano, K. Teramoto, S. Chung, and Y. Nakamura A systematic approach to the development of novel therapeutics for lung cancer using genomic analyses Clin Pharmacol Ther 94 2013 218 223
4. S.M. Paul, D.S. Mytelka, and C.T. Dunwiddie How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat Rev Drug Discov 9 2010 203 214
5. L. Hutchinson, and R. Kirk High drug attrition rates-where are we going wrong? Nat Rev Clin Oncol 8 2011 189 190
6. E.H. Rubin, and D.G. Gilliland Drug development and clinical trials-the path to an approved cancer drug Nat Rev Clin Oncol 9 2012 215 222
7. T. Li, H.J. Kung, P.C. Mack, and D.R. Gandara Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies J Clin Oncol 31 2013 1039 1049
8. D.R. Gandara, T. Li, and P.N. Lara Jr. Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneity Clin Lung Cancer 13 2012 321 325
9. F.S. Collins Reengineering translational science: the time is right Sci Transl Med 3 2011 90cm17
10. R. Rosell, N. Karachaliou, and D. Morales-Espinosa Adaptive resistance to targeted therapies in cancer Transl Lung Cancer Res 2 2013 152 159
11. D.R. Gandara, T. Li, and P.N. Lara Acquired resistance to targeted therapies against oncogene-driven non-small-cell lung cancer: approach to subtyping progressive disease and clinical implications Clin Lung Cancer 15 2014 1 6
12. A. Gower, Y. Wang, and G. Giaccone Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer J Mol Med (Berl) 92 2014 697 707
13. Y. Iwasa, and F. Michor Evolutionary dynamics of intratumor heterogeneity PLoS One 6 2011 e17866
14. K. Politi, and W. Pao How genetically engineered mouse tumor models provide insights into human cancers J Clin Oncol 29 2011 2273 2281
15. B.S. Carver, and P.P. Pandolfi Mouse modeling in oncologic preclinical and translational research Clin Cancer Res 12 2006 5305 5311
16. N.E. Sharpless, and R.A. Depinho The mighty mouse: genetically engineered mouse models in cancer drug development Nat Rev Drug Discov 5 2006 741 754
17. L. Regales, M.N. Balak, and Y. Gong Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors PLoS One 2 2007 e810
18. Z. Weaver, S. Difilippantonio, and J. Carretero Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response Cancer Res 72 2012 5921 5933
19. J.J. Tentler, A.C. Tan, and C.D. Weekes Patient-derived tumour xenografts as models for oncology drug development Nat Rev Clin Oncol 9 2012 338 350
20. L.D. Shultz, F. Ishikawa, and D.L. Greiner Humanized mice in translational biomedical research Nat Rev Immunol 7 2007 118 130
21. K.P. Olive, and D.A. Tuveson The use of targeted mouse models for preclinical testing of novel cancer therapeutics Clin Cancer Res 12 2006 5277 5287
22. M. Hidalgo, E. Bruckheimer, and N.V. Rajeshkumar A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer Mol Cancer Ther 10 2011 1311 1316
23. T. John, D. Kohler, and M. Pintilie The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small-cell lung cancer Clin Cancer Res 17 2011 134 141
24. C.J. Bult, D.M. Krupke, and D.A. Begley Mouse Tumor Biology (MTB): a database of mouse models for human cancer Nucleic Acids Res 43 Database issue 2015 D818 D824
25. D.R. Gandara, P. Grimminger, and P.C. Mack Association of epidermal growth factor receptor activating mutations with low ERCC1 gene expression in non-small-cell lung cancer J Thorac Oncol 5 2010 1933 1938
26. M.K. Maus, P.P. Grimminger, and P.C. Mack KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies Lung Cancer 83 2014 163 167